Development of poly(lactide-co-glycolide) nanoparticles functionalized with a mitochondria penetrating peptide.
J Pept Sci
; 23(2): 182-188, 2017 Feb.
Article
em En
| MEDLINE
| ID: mdl-28093876
ABSTRACT
The development of mitochondria-targeting cell permeable vectors represents a promising therapeutic approach for several diseases, such as cancer and oxidative pathologies. Nevertheless, access to mitochondria can be difficult. A new hybrid material composed by poly(lactide-co-glycolide) (PLGA) functionalized with a 6-mer mitochondria penetrating peptide (MPP), consisting in alternating arginine and unnatural cyclohexylalanine, was developed. Circular dichroism, FT-IR and DSC studies indicated that the conjugation of the peptide with the polymer led to the obtainment of a more rigid material with respect to both PLGA and MPP as such. In particular, a conformational rearrangement to a helical structure was observed for MPP. MPP-PLGA conjugates were used for the preparation of nanoparticles that showed no cytotoxicity in MTT assay, suggesting their putative use for future studies on mitochondria targeting. Copyright © 2017 European Peptide Society and John Wiley & Sons, Ltd.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Peptídeos
/
Poliglactina 910
/
Portadores de Fármacos
/
Nanopartículas
Limite:
Humans
Idioma:
En
Ano de publicação:
2017
Tipo de documento:
Article